Skip to main content
SpringerLink
Log in

Effect of Metformin on Metabolic Parameters and Hypothalamic Signaling Systems in Rats with Obesity Induced by a High-Carbohydrate and High-Fat Diet

  • Published:
Advances in Gerontology Aims and scope Submit manuscript

Abstract

Metformin (MF), a first-line drug in the treatment of diabetes mellitus, has been used in recent years to treat obesity. Its therapeutic effect is due not only to the influence on the peripheral tissues but also on the hypothalamus, which controls food behavior and energy metabolism. The goal was to study the effect of MF therapy (200 mg/kg/day, 8 weeks) in rats with obesity caused by a high-carbohydrate and high-fat diet on metabolic and hormonal parameters and the functional state of the hypothalamic signaling systems. MF treatment of obese rats (the group ObM) normalized food behavior; reduced the body weight and fat weight and the glucose, insulin, and leptin levels; increased sensitivity to glucose and insulin; improved the lipid metabolism; and restored Ser473 phosphorylation of Akt kinase in the liver. In the hypothalamus, the stimulating effects of agonists of type-4 melanocortin receptor and type-1 dopamine receptor on adenylyl cyclase (AC) were partially restored, the inhibitory effect on AC of agonists of subtype-1B serotonin receptor (5-HT1BR) increased (which was associated with an increase in Htr1b gene expression), and the stimulating effect of the 5-HT6R agonist EMD-386088 normalized. At the same time, the differences in the activity of the leptin and insulin systems and the ratio of anorexigenic and orexigenic factors in the hypothalamus of the rat groups Ob and ObM were insignificant. Thus, MF treatment changes the functional activity of the hypothalamic melanocortin, dopamine, and serotonin systems in obese rats, which is one way to decrease their food intake and to restore the metabolic parameters and insulin sensitivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

Similar content being viewed by others

REFERENCES

  1. Derkach, K.V., Ivantsov A.O., Chistyakova, O.V., Sukhov I.B., Buzanakov D.M., Kulikova A.A., and Shpakov, A.O., Intranasal insulin restores metabolic parameters and insulin sensitivity in rats with metabolic syndrome, Bull. Exp. Biol. Med., 2017, vol. 163, no. 2, pp. 184–189.

    Article  PubMed  CAS  Google Scholar 

  2. Sukhov I.B., Derkach, K.V., Chistyakova, O.V., Bondareva V.M., and Shpakov, A.O., Functional state of hypothalamic signaling systems in rats with type 2 diabetes mellitus treated with intranasal insulin, J. Evol. Biochem. Physiol., 2016, vol. 52, no. 3, pp. 204–216.

    Article  CAS  Google Scholar 

  3. Shpakov, A.O., Functional activity of the insulin signaling system of the brain in health and type 2 diabetes mellitus, Neurosci. Behav. Physiol., 2017, vol. 47, no. 2, pp. 190–203.

    Article  CAS  Google Scholar 

  4. Shpakov, A.O., The brain leptin signaling system and its functional state in metabolic syndrome and type 2 diabetes mellitus, J. Evol. Biochem. Physiol., 2016, vol. 52, no. 3, pp. 177–195.

    Article  CAS  Google Scholar 

  5. Shpakov, A.O. and Derkach, K.V., Molecular mechanisms of influence of metformin on the functional activity of brain neurons, Ross. Fiziol. Zh. im. I.M. Sechenova, 2017, vol. 103, no. 5, pp. 504–517.

    Google Scholar 

  6. Banks, W.A. and Farrell, C.L., Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible, Am. J. Physiol., 2003, vol. 285, no. 1, pp. 10–15.

    Google Scholar 

  7. Cakir, I., Cyr, N.E., Perello, M., et al., Obesity induces hypothalamic endoplasmic reticulum stress and impairs proopiomelanocortin (POMC) post-translational processing, J. Biol. Chem., 2013, vol. 288, no. 24, pp. 17675–17688.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Derkach, K.V., Bogush, I.V., Berstein, L.M., and Shpakov, A.O., The influence of intranasal insulin on hypothalamic-pituitary-thyroid axis in normal and diabetic rats, Horm. Metab. Res., 2015, vol. 47, no. 12, pp. 916–924.

    Article  PubMed  CAS  Google Scholar 

  9. Derkach, K.V., Bondareva, V.M., Chistyakova, O.V., et al., The effect of long-term intranasal serotonin treatment on metabolic parameters and hormonal signaling in rats with high-fat diet/low-dose streptozotocin- induced type 2 diabetes, Int. J. Endocrinol., 2015, vol. 2015, art. ID 245459. doi 10.1155/2015/245459

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Doslikova, B., Garfield, A.S., Shaw, J., et al., 5-HT2C receptor agonist anorectic efficacy potentiated by 5-HT1B receptor agonist co-application: an effect mediated via increased proportion of pro-opiomelanocortin neurons activated, J. Neurosci., 2013, vol. 33, no. 23, pp. 9800–9804.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. El-Haschimi, K., Pierroz, D.D., Hileman, S.M., et al., Two defects contribute to hypothalamic leptin resistance in mice with dietinduced obesity, J. Clin. Invest., 2000, vol. 105, pp. 1827–1832.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Foretz, M., Guigas, B., Bertrand, L., et al., Metformin: from mechanisms of action to therapies, Cell Metab., 2014, vol. 20, no. 6, pp. 953–966.

    Article  PubMed  CAS  Google Scholar 

  13. Franco, R., Martínez-Pinilla, E., Lanciego, J.L., and Navarro, G., Basic pharmacological and structural evidence for Class A G-protein-coupled receptor heteromerization, Front. Pharmacol., 2016, vol. 7, p. 76.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Hawley, S.A., Ross, F.A., Chevtzoff, C., et al., Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation, Cell Metab., 2010, vol. 11, no. 6, pp. 554–565.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Heisler, L.K., Jobst, E.E., Sutton, G.M., et al., Serotonin reciprocally regulates melanocortin neurons to modulate food intake, Neuron, 2006, vol. 51, no. 2, pp. 239–249.

    Article  PubMed  CAS  Google Scholar 

  16. Higgs, S., Cooper, A.J., and Barnes, N.M., The 5‑HT2C receptor agonist, lorcaserin, and the 5-HT6 receptor antagonist, SB-742457, promote satiety; a microstructural analysis of feeding behavior, Psychopharmacology (Heidelberg), 2016, vol. 233, no. 3, pp. 417–424.

    Article  CAS  Google Scholar 

  17. Hostalek, U., Gwilt, M., and Hildemann, S., Therapeutic use of metformin in prediabetes and diabetes prevention, Drugs, 2015, vol. 75, no. 10, pp. 1071–1094.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Hou, M., Venier, N., Sugar, L., et al., Protective effect of metformin in CD1 mice placed on a high carbohydrate-high fat diet, Biochem. Biophys. Res. Commun., 2010, vol. 397, no. 3, pp. 537–542.

    Article  PubMed  CAS  Google Scholar 

  19. Igel, L.I., Sinha, A., Saunders, K.H., et al., Metformin: an old therapy that deserves a new indication for the treatment of obesity, Curr. Atheroscler. Rep., 2016, vol. 18, no. 4, pp. 16. doi 10.1007/s11883–016–0568–3

    Article  PubMed  CAS  Google Scholar 

  20. López, M., EJE PRIZE 2017: Hypothalamic AMPK: a golden target against obesity?, Eur. J. Endocrinol., 2017, vol. 176, no. 5, pp. 235–246.

    Article  Google Scholar 

  21. López, M., Nogueiras, R., Tena-Sempere, M., and Diéguez, C., Hypothalamic AMPK: a canonical regulator of whole-body energy balance, Nat. Rev. Endocrinol., 2016, vol. 12, no. 7, pp. 421–432.

    Article  PubMed  CAS  Google Scholar 

  22. Lv, W.S., Wen, J.P., Li L., et al., The effect of metformin on food intake and its potential role in hypothalamic regulation in obese diabetic rats, Brain Res., 2012, vol. 1444, pp. 11–19.

    Article  PubMed  CAS  Google Scholar 

  23. Matsui, Y., Hirasawa, Y., Sugiura, T., et al., Metformin reduces body weight gain and improves glucose intolerance in high-fat diet-fed C57BL/6J mice, Biol. Pharm. Bull., 2010, vol. 33, no. 6, pp. 963–970.

  24. Paolisso, G., Amato, L., Eccellente, R., et al., Effect of metformin on food intake in obese subjects, Eur. J. Clin. Invest., 1998, vol. 28, no. 6, pp. 441–446.

    Article  PubMed  CAS  Google Scholar 

  25. Perreault, M.L., Hasbi, A., O’Dowd, B.F., and George, S.R., Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance, Neuropsychopharmacology, 2014, vol. 39, no. 1, pp. 156–168.

    Article  PubMed  CAS  Google Scholar 

  26. Sakai, G., Inoue, I., Suzuki, T., et al., Effects of the activation of three major hepatic Akt substrates on glucose metabolism in male mice, Endocrinology, 2017, vol. 158, no. 8, pp. 2659–2671.

    Article  PubMed  Google Scholar 

  27. Seifarth, C., Schehler, B., and Schneider, H.J., Effectiveness of metformin on weight loss in non-diabetic individuals with obesity, Exp. Clin. Endocrinol. Diabetes, 2013, vol. 121, no. 1, pp. 27–31.

    PubMed  CAS  Google Scholar 

  28. Shpakov, A.O., Derkach, K.V., and Berstein, L.M., Brain signaling systems in the type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases, Future Sci. OA, 2015, vol. 1, no. 3, p. FSO25. doi 10.4155/fso.15.23

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  29. Stevanovic, D., Janjetovic, K., Misirkic, M., et al., Intracerebroventricular administration of metformin inhibits ghrelin-induced hypothalamic AMP-kinase signaling and food intake, Neuroendocrinology, 2012, vol. 96, no. 1, pp. 24–31.

    Article  PubMed  CAS  Google Scholar 

  30. Yang, X., Xu, Z., Zhang, C., et al., Metformin, beyond an insulin sensitizer, targeting heart and pancreatic β cells, Biochim. Biophys. Acta, 2017, vol. 1863, no. 8, pp. 1984–1990.

    Article  CAS  Google Scholar 

Download references

ACKNOWLEDGMENTS

The work was supported by the Russian Science Foundation (project no. 16-15-10388).

Author information

Authors and Affiliations

  1. Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, 194223, St. Petersburg, Russia

    K. V. Derkach, I. B. Sukhov, V. M. Bondareva & A. O. Shpakov

Authors
  1. K. V. Derkach
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. B. Sukhov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. M. Bondareva
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. O. Shpakov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. O. Shpakov.

Additional information

Translated by E. Sherstyuk

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Derkach, K.V., Sukhov, I.B., Bondareva, V.M. et al. Effect of Metformin on Metabolic Parameters and Hypothalamic Signaling Systems in Rats with Obesity Induced by a High-Carbohydrate and High-Fat Diet. Adv Gerontol 8, 228–234 (2018). https://doi.org/10.1134/S2079057018030037

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S2079057018030037

Keywords:

Search

Navigation